System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Cristina Has is an expert in Dermatology at University Medical Center Freiburg (Germany). As of October 2026, ScienceLeadR ranks Cristina Has in the top 1% of experts worldwide for Skin Abnormalities, Keratosis and Congenital Abnormalities. Cristina Has has authored 369 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,242 (community average: 125). How the SLR is computed.

LeadR Profile

Cristina Has University Medical Center Freiburg Germany
1 242 ScienceLeadR Reputation 1242

Unlock

Register Login
Network Map

Dermatology

Subspecialties: Genetics - Biochemistry - Dentistry

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2003 - 2026
Source: PubMed

University of Freiburg

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 369

Citations

Citations: 8 512 1st author: 56 Last author: 122 Unique author: 34

Main journals

J Invest Dermatol 55
Br J Dermatol 48
J Dtsch Dermatol Ges 31
J Eur Acad Dermatol Venereol 23
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature 17

Best Journals

N Engl J Med 1
Nat Rev Dis Primers 1

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Distinct responses of COL17A1 nonsense variants to readthrough drugs and NOG as a novel enhancer in junctional epidermolysis bullosa.
PMID 42824587 — skin, pharmaceutical preparations, oligonucleotides, epidermolysis bullosa, junctional, epidermolysis bullosa, aminoglycosides, therapeutics, enhancer elements, genetic, mutation		Mol Ther Nucleic Acids20260
Bimekizumab as an Effective Treatment in Darier Disease: Clinical Outcomes of a Single-Center Retrospective Analysis of Patients Treated with Biologics.
PMID 42728531 — darier disease, therapeutics, biological factors		Dermatol Ther (Heidelb)20260
Gene Therapy for Dystrophic Epidermolysis Bullosa.
PMID 42568047 — skin, cells, genes, epidermolysis bullosa dystrophica, phenotype, skin diseases, epidermolysis bullosa, keratinocytes, fibroblasts, therapeutics		Exp Dermatol20260
The uncertainty of EDD.
PMID 42538809 — uncertainty, dermatology		Clin Exp Dermatol20260
Consensus Recommendations for Management of Darier Disease: A Practical Approach.
PMID 42455252 — genes, retinoids, quality of life, genetic testing, darier disease, diagnosis, therapeutics, wounds and injuries		Dermatol Ther (Heidelb)20260

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 1/Phase 2 1

By status:

Completed 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 0
multicentric5to9 1
multicentricup10 0

Main Topics

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS